Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial.
Li Z, Dang X, Huang D, Jin S, Li W, Shi J, Wang X, Zhang Y, Song Z, Zhang J, Zhuang W, Liu X, Jiang L, Meng X, Zhao M, Zhou J, Zhang L, Wang P, Luo H, Yang J, Cang S, Wang X, Zhang L, Lu S; D1553–102 Study Group.
Li Z, et al. Among authors: jin s.
Lancet Respir Med. 2024 Jun 10:S2213-2600(24)00110-3. doi: 10.1016/S2213-2600(24)00110-3. Online ahead of print.
Lancet Respir Med. 2024.
PMID: 38870979